HSBC Research has published a research report, listing the investment ratings and target prices for Chinese pharmaceutical stocks as follows:

Stock | Investment Rating | Target Price (HKD)

Pharmaceutical stocks

FOSUN PHARMA (02196.HK) | Hold | 13 yuan

HANSOH PHARMA (03692.HK) | Buy | 22 yuan

CHINA NATIONAL PHARMACEUTICAL GROUP (01177.HK) | Buy | 4.1 yuan

CSPC PHARMA (01093.HK) | Hold | 5.2 yuan

CMS (00867.HK) | Buy | 9.5 yuan

LIVZON PHARMA (01513.HK) | Buy | 34 yuan

Pharmaceutical company

BEIGENE (06160.HK) | Buy | 177 yuan

INNOVENT BIO (01801.HK) | Buy | 53 yuan

SKB BIO-B (06990.HK) | Buy | 237 yuan

Hutchmed (China) (HCM.L) | Buy | 415 pence

Equipment

TIGERMED (03347.HK) | Buy | 47.4 yuan

Pharmacy

SINOPHARM (01099.HK) | Hold | 19 yuan

SH PHARMA (02607.HK) | Buy | 17.6 yuan

Distributor

GUSHENGTANG (02273.HK) | Buy | 55 yuan

HYGEIA HEALTH (06078.HK) | Buy | 25 yuan

Service

ADICON HOLDINGS (09860.HK) | Hold | 7.2 yuan